WallStreetZenWallStreetZen

NASDAQ: NLSP
Nls Pharmaceutics Ltd Stock Ownership - Who owns Nls Pharmaceutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nls Pharmaceutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NLSP insiders and whales buy or sell their stock.

NLSP Shareholders

What type of owners hold Nls Pharmaceutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc14.58%143,676$209.77kInstitution
Ubs Group Ag0.84%8,292$12.11kInstitution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

NLSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NLSP15.42%0.00%
PLRZ1.99%0.00%
PTIX1.99%0.61%
PBM7.76%92.24%
SLRX0.06%99.94%
View Top Biotech Stocks

Nls Pharmaceutics Stock Ownership FAQ

Who owns Nls Pharmaceutics?

Nls Pharmaceutics (NASDAQ: NLSP) is owned by 15.42% institutional shareholders, 0.00% Nls Pharmaceutics insiders, and 84.58% retail investors. Bvf Inc is the largest individual Nls Pharmaceutics shareholder, owning 143,676.00 shares representing 14.58% of the company. Bvf Inc's Nls Pharmaceutics shares are currently valued at $208.33k.

If you're new to stock investing, here's how to buy Nls Pharmaceutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.